Hongkui Deng

Director of the Institute of Stem Cell Research at Peking University and co-founder and Chief Scientific Advisor at Reprogenics Bioscience. His work laid the foundation for chemically induced pluripotent stem cells and their application in clinical therapies.

Best podcasts with Hongkui Deng

Ranked by the Snipd community

Jun 17, 2025 • 1h 1min

Ep. 297: “Live at ISSCR 2025: Advancing Regenerative Medicine with CiPSCs” Featuring Drs. Hongkui Deng and Candice Liew

Dr. Hongkui Deng, Director of the Institute of Stem Cell Research at Peking University, and Dr. Candice Liew, Senior Scientist at Reprogenix Bioscience, share their groundbreaking work on chemically induced pluripotent stem cells (CiPSCs). They discuss a revolutionary patient trial using CiPSC-derived islets for type 1 diabetes and the challenges of immune tolerance. The pair also delve into advancements in chemical reprogramming and their potential to transform regenerative medicine, including innovative strategies for age reversal and enhanced disease treatment.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app